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Abstract 
Purpose: Loose fragments in osteochondritis dissecans (OCD) of the knee require internal fixations. On the 
other hand, loose fragments derived from spontaneous osteonecrosis of the knee (SONK) are usually 
removed. However, the difference in healing potential between OCD- and SONK-related loose fragments has 
not been elucidated. In this study, we investigated proliferative activity and redifferentiation potential of 
normal cartilage- and loose fragment-derived chondrocytes. 
Methods: Cells were prepared from normal articular cartilages and loose fragment cartilages derived from 
knee OCD and SONK. Cellular proliferation was compared. Redifferentiation ability of pellet-cultured 
chondrocytes was assessed by real-time PCR analyses. Mesenchymal differentiation potential was 
investigated by histological analyses. Positive ratio of a stem cell marker CD166 was evaluated in each 
cartilaginous tissue. 
Results: Normal and OCD chondrocytes showed a higher proliferative activity than SONK chondrocytes. 
Chondrogenic pellets derived from normal and OCD chondrocytes produced a larger amount of safranin 
O-stained proteoglycans compared with SONK-derived pellets. Expression of chondrogenic marker genes 
was inferior in SONK pellets. CD166-positive ratio was higher in normal cartilages and OCD loose 
fragments than in SONK loose fragments. 
Conclusions: OCD chondrocytes maintained higher proliferative activity and redifferentiation potential 
compared with SONK chondrocytes. Our results suggest that chondrogenic properties of loose 
fragment-derived cells and the amount of CD166-positive cells may affect the repairing process of 
osteochondral defects. 
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Introduction 
Osteochondritis dissecans (OCD) is a condition affecting the subchondral bone with secondary 
effects on articular cartilage that results in pain, effusions, and loose fragment formation. OCD of the knee 
causes knee pain and dysfunction among skeletally immature (juvenile) and young adult patients [1]. Several 
etiologies of knee OCD has been proposed, including repetitive microtrauma, genetics, vascular, mechanical 
axis malalignment, and discoid lateral meniscus [2, 3]. Based on the histologic findings, the initial change of 
knee OCD is bone necrosis or subchondral fracture [4]. Management of knee OCD includes nonoperative 
measures or operative procedures such as drilling, fragment fixation, and osteochondral autograft (allograft) 
[1]. Internal fixation of OCD loose fragment using bioabsorbable screws, pins, and osteochondral plugs 
shows excellent clinical outcomes and high healing rates [1, 5]. On the other hand, osteochondral loose 
fragments derived from spontaneous osteonecrosis of the knee (SONK) are usually removed by surgical 
treatments [6]. SONK is clinically characterized by a sudden onset of severe knee pain in elderly patients. 
Traumatic and vascular theories have been proposed as a causative factor of SONK involving a subchondral 
insufficiently fracture of the femoral condyle [6]. Histological analyses have revealed that osteonecrotic 
lesions between the subchondral fracture line and the articular surface are observed in the advanced stage of 
SONK [7]. Conservative treatments that include protected weight-bearing and the use of bisphosphonate are 
effective in the early stage of SONK [8]. In the progressive and advanced stages of SONK, surgical 
treatments that include drilling, core decompression, artificial bone graft, osteochondral autograft (allograft), 
high tibial osteotomy, and unicompartmental or total knee arthroplasty may be required [6, 9]. We previously 
demonstrated that SONK loose fragment chondrocytes had low potentials in cellular proliferation and 
redifferentiation [10]. However, the differences among normal cartilage-, OCD-, and SONK-derived 
chondrocytes remain unclear in their regeneration potentials. Human chondrocytes isolated from detached 
OCD fragments maintain similar cell viability to those from healthy normal cartilages [11]. On the other 
hand, chondrogenic redifferentiation potential of horse OCD-derived chondrocytes seems to be inferior to 
that of normal chondrocytes because OCD chondrocytes show lower expression of a chondrogenic 
transcription factor, Sry-type high-mobility-group box (SOX) 9 [12]. In this study, we investigated 
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proliferative activity, redifferentiation ability, and expression of chondrogenic marker genes in chondrocytes 
derived from normal cartilages, OCD loose fragments, and SONK loose fragments. 
 
Methods 
Tissues, cells, and cell culture 
Normal articular cartilages were obtained at notchplasty in patients (13, 18, 19, and 21 years of 
age) underwent anterior cruciate ligament reconstructions (n = 4). Unnecessary parts of loose fragments in 
knee OCD (15, 15, 15, and 21 years of age) were obtained at arthroscopic surgeries (n = 4). Osteonecrotic 
loose fragments were obtained at knee arthroplasty in patients (62, 64, 65, and 66 years of age) suffering 
from SONK (n = 4). Demographic data of the patients were shown as Table. This study received the approval 
of our Institutional Review Board and the informed consents for this research were obtained from patients. 
The diagnosis was established according to clinical findings and magnetic resonance imaging. OCD lesions 
were arthroscopically evaluated by the International Cartilage Repair Society (ICRS) classification (ICRS 
OCD II, III, IV, and IV in each patient; Table) [13]. Radiographic stages of SONK (stage III in all patients) 
were assessed by Koshino’s classification (Table) [9]. Articular cartilage was carefully separated from 
osteochondral fragments. Normal and loose fragment chondrocytes were prepared by collagenase (Sigma, St. 
Louis, MO) digestion [14]. Cells were maintained with Dulbecco’s modified Eagle’s medium (DMEM, 
Wako, Osaka, Japan) containing fetal bovine serum (HyClone, South Logan, UT) and penicillin/streptomycin 
(Sigma). Chondrocytes between passage 1 and 3 were used in this study. Tissue samples were fixed with 4% 
paraformaldehyde-buffered solution. Decalcified paraffin-embedded tissue sections were prepared for 
histological analyses. 
Cell proliferation assay 
 Cell proliferation assays were performed as described [15]. In brief, cultured cells were plated as 
2.5 x 103 cells/well and incubated for 12 h. Then, cells were harvested for 0, 24, 48, and 72 h before addition 
of water soluble tetrazolium (WST)-1 reagents (Roche, Mannheim, Germany). Optical density (OD) was 
measured by iMark microplate reader (Bio-Rad, Hercules, CA) after 3-h-treatment of WST-1. Data obtained 
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by subtracting 630-nm readings from 450-nm readings were used for evaluation. The mean value derived 
from 5 wells was evaluated. 
In vitro differentiation and histological analyses 
In vitro differentiation was performed as described [16]. For chondrogenic redifferentiation, 
pelleted micromass culture was performed. Pellet-cultured cells (5 x 105 cells/pellet) were maintained in the 
chondrogenic induction medium supplemented with 10 ng/ml of recombinant human bone morphogenetic 
protein (BMP)-2 (kindly provided from Pfizer, New York, NY) and transforming growth factor-β3 (R&D 
Systems, Minneapolis, MN) for 3 weeks [17]. Proteoglycans in pellets were observed with safranin O 
staining. Redifferentiation potential was assessed by the Bern pellet histology score (range, 0-9) [18, 19]. To 
assess the effect of tissue-derived mesenchymal stem cells (MSCs), we performed in vitro differentiation 
analysis towards the other mesenchymal lineages. To induce adipogenic differentiation, confluent cells were 
cultured with adipogenesis induction and maintenance media for 3 weeks according to the manufacturer’s 
protocol (Millipore, Billerica, MA). Lipid vacuoles were stained with oil red O solution [20]. Osteogenic 
induction was performed using MSC osteogenesis kit (Millipore) and 1 ng/ml of BMP-2 for 3 weeks. 
Calcium deposition was visualized by von Kossa staining. Tissue specimens of osteochondral fragments 
were immunostained by a rabbit anti-CD166 antibody (ALCAM H-108, 1:100, Santa Cruz, Santa Cruz, CA) 
for detecting a cell surface marker of MSCs and progenitor cells [21]. Staining density of oil red O, von 
Kossa, and CD166 was quantified by Image J 1.31 [15]. Relative staining density was normalized by a mean 
value derived from 5 different images of SONK chondrocytes. CD166-positive cell ratio was evaluated by a 
microscopic counting of chondrocytes in 5 different areas. 
Quantitative real-time PCR analyses 
RNAs purified from chondrogenic pellets were reverse-transcribed with ReverTra Ace (Toyobo, 
Osaka, Japan). Quantitative real-time PCR analyses were performed using LightCycler ST-300 and FastStart 
DNA Master SYBR Green I kit (Roche). Chondrogenic redifferentiation was assessed using the primers for 
SOX9, SOX5/6, and α1(II) collagen (COL2A1) [16, 20]. Amplification of glyceraldehyde-3-phosphate 
dehydrogenase (G3PDH) was used for normalization [16]. The cycle number crossing the signal threshold 
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was selected in the linear part of the amplification curve. Relative mRNA levels were normalized with the 
level of SONK-derived pellets. 
Statistical analysis 
All experiments were repeated three times and similar results were obtained. The data presented in 
the figures 1-4 were derived from the same patients (normal, 18 years old; OCD, 15 years old; SONK, 66 
years old). Data were expressed as means with standard deviations. Mean values were compared with a 
one-way ANOVA. Post hoc comparisons were performed using the Tukey test. Significance was set at p < 
0.05. 
 
Results 
Proliferative activity of chondrocytes 
Chondrocytes derived from normal cartilages and OCD loose fragments showed a higher 
proliferative activity than SONK chondrocytes (Fig. 1, a-c). OCD chondrocytes showed a similar 
proliferative activity to normal chondrocytes (Fig. 1, a and b). On the other hand, cellular proliferation of 
SONK chondrocytes was inferior to that of normal chondrocytes (Fig. 1, a and c).  
Redifferentiation potential of chondrocytes 
In vitro differentiation analyses revealed that normal and OCD chondrogenic pellets produced the 
larger amount of proteoglycans compared with SONK-derived pellets (Fig. 2, a-c). The Bern pellet histology 
score was higher in normal and OCD chondrocyte-derived pellets than in SONK chondrogenic pellets (Fig. 
2d). Lipid vacuoles were observed in normal and OCD chondrocytes after adipogenic induction (Fig. 2, a 
and b). In addition, osteogenic treatments induced calcium depositions in normal cartilage-derived cells and 
OCD loose fragment cells (Fig. 2, a and b). On the other hand, neither adipogenesis nor osteogenesis was 
induced in SONK loose fragment-derived cells (Fig. 2c). Staining density of oil red O and von Kossa was 
lower in SONK-derived cells than in normal cartilage- and OCD-derived cells after the induction for each 
mesenchymal lineage (Fig. 2, e and f). Gene expression pattern indicated that redifferentiation potential of 
OCD chondrocytes was higher than that of SONK chondrocytes (Fig. 3). Expression of COL2A1 and SOX9 
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was more activated in normal and OCD chondrogenic pellets than SONK pellets (Fig. 3, a and b). However, 
expression of SOX5/6 was not highly induced in normal and OCD pellets by chondrogenic treatments (Fig. 3, 
c and d). 
CD166-positive cells in loose fragment cartilages 
CD166, a MSC surface marker, was detected in chondrocytes packaged in normal cartilages (Fig. 
4a). In addition, CD166-positive cells were observed in loose fragment cartilages of OCD and SONK (Fig. 4, 
b and c). However, CD166-positive cell ratio was higher in normal cartilages and OCD loose fragments than 
in SONK-derived fragments (Fig. 4e). Relative CD166 staining density was also higher in normal and OCD 
cartilage samples than in SONK loose fragments (Fig. 4f). 
 
Discussion 
 Osteonecrotic loose fragment and unstable cartilage flap in SONK are usually removed at surgical 
treatment [6, 9]. On the other hand, fixation of OCD loose fragment shows excellent clinical outcomes and 
high healing rates [1, 5]. However, these reports have not mentioned the difference between SONK- and 
OCD-derived loose fragment chondrocytes in cellular potential. The present study demonstrated that OCD 
loose fragment chondrocytes maintained similar proliferative and redifferentiation potentials to normal 
chondrocytes and that SONK loose fragment chondrocytes showed a lower activity in cellular proliferation 
and redifferentiation. 
Monolayer-cultured articular chondrocytes leads to a process of dedifferentiation whereby the cells 
acquire a fibroblastic morphology and lose their chondrocytic properties [22]. The expression of 
chondrocyte-specific genes, such as COL2A1, aggrecan, SOX9, and SOX5/6, is gradually down-regulated 
during cell multiplication in monolayer culture conditions [22]. We previously demonstrated that COL2A1 
expression was not detected in monolayer-cultured (dedifferentiated) SONK chondrocytes, whereas type II 
collagen deposition and COL2A1 expression were observed in tissue samples of SONK loose fragment 
cartilages [10]. Aging also influences cellular properties. Aged human chondrocytes are inferior to juvenile 
chondrocytes in producing cartilage-specific extracellular matrix [23]. In cell proliferation and chondrogenic 
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redifferentiation, aged human chondrocytes show lower cellular potentials rather than chondrocytes derived 
from younger donors [24]. Our study demonstrated that aged SONK chondrocytes are inferior to normal and 
OCD chondrocytes in cellular proliferation (Fig. 1). In addition, three-dimensional-cultured SONK 
chondrocytes showed lower chondrogenic phenotypes than normal cartilage- and OCD-derived 
chondrogenic pellets (Fig. 2 and 3). On the other hand, OCD loose fragment chondrocytes maintained 
similar chondrogenic phenotypes to normal articular chondrocytes (Fig. 2 and 3). These findings suggest that 
chondrocyte aging may be a key factor in reducing its proliferative activity and redifferentiation potential. 
MSCs are multipotent cells that differentiate into chondrogenic, adipogenic, and osteogenic 
lineages [25]. Several tissue-derived MSCs, such as bone marrow, synovium, adipose, ligament, and 
meniscus, are candidates for a cell source of regeneration for damaged tissue [16, 20, 25]. However, few 
reports investigate the cellular behavior of MSCs packaged in articular cartilage [21, 26]. These literatures 
focus on CD166 as a biomarker to identify cartilage-derived MSCs and/or progenitor cells in both normal 
and osteoarthritic cartilages [21, 26]. Primary cell culture from aged osteoarthritic cartilages (ranged from 59 
to 87 years old) shows a higher rate of CD105/CD166-positive progenitor cells than that from younger 
normal cartilages (ranged from 17 to 39 years old) [26]. On the other hand, Pretzel et al. have demonstrated 
that the ratio of CD105/CD166-positive progenitor cells is similar between osteoarthritic chondrocytes and 
normal chondrocytes using flow cytometry [21]. Percentage of CD166-positive cells is also similar between 
osteoarthritic and normal cartilage in immunohistological analysis [21]. In our study, CD166-positive cell 
ratio and relative CD166 staining density were higher in OCD fragments and normal cartilages than in 
SONK loose fragments (Fig. 4). These findings suggest that CD166-positive cell ratio is not determined in an 
age-dependent manner. The ratio of CD166-positive cells might represent the status of intrinsic repair 
capacity in articular cartilage. We consider that the healing potential of osteoarthritic chondrocytes might be 
preserved (or transiently activated) by an excessive mechanical stress. However, CD166-positive cells might 
not be induced in SONK detached fragment chondrocytes for lack of mechanical loading. MSCs secrete a 
variety of growth factors that stimulate mitosis and differentiation of tissue-intrinsic progenitor cells [27]. 
MSC-mediated trophic effect is distinct from the direct differentiation of MSCs into repairing tissue. On the 
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other hand, cryopreserved human cartilage fragments promote chondrogenic differentiation of human bone 
marrow-derived MSCs in a nude mouse transplantation model [28]. These findings suggest that the 
interaction between CD166-positive cells and primitive MSCs may have an essential role in enhancing 
cartilage repair. However, further studies involved in the other MSC markers, such as CD44, 73, 90, and 105, 
will be required to understand the precise role of cartilage-derived progenitor cells and MSCs. 
Chondrogenic differentiation and maturation are cooperatively regulated by several transcription 
factors and coactivators [17, 29, 30]. Chondrogenic master transcription factor SOX9 positively regulates the 
expression of its target genes through the association with the consensus DNA sequences (WWCAAWG) on 
promoters and enhancers of cartilage-specific genes, such as COL2A1, α1(IX), α2(XI) collagen, aggrecan, 
and cartilage link protein [30]. SOX9-associating coactivators including p300, Smad3, and E47 have 
important roles in modulating SOX9-dependent transcriptional activation [30]. Our results indicated that 
SOX9 expression was higher in normal and OCD chondrocytes than in SONK chondrocytes during 
redifferentiation procedure (Fig. 3). However, the expression of SOX9-supporting molecule SOX5/6 in 
normal cartilage- and OCD-derived chondrogenic pellets was similar to that in SONK-derived pellets (Fig. 
3). These findings suggest that SOX9-associating molecules and other chondrogenic factors except SOX5/6 
would have fundamental roles in enhancing chondrogenic redifferentiation. 
 In conclusion, our experimental study demonstrated that articular chondrocytes derived from 
normal cartilage and detached OCD loose fragment maintained higher proliferative activity and 
redifferentiation potential compared with SONK loose fragment chondrocytes. Our results suggest that the 
proliferative and redifferentiation properties of chondrocytes and the amount of CD166-positive cells in 
loose fragment cartilages may affect the repairing process of osteochondral defects. 
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Figure legends 
Fig. 1. Normal chondrocytes and OCD loose fragment chondrocytes showed a higher proliferative activity 
than SONK loose fragment chondrocytes in cell proliferation assays. Normal chondrocytes (a). OCD-derived 
chondrocytes (b). SONK-derived chondrocytes (c). *p < 0.05. 
 
Fig. 2. Normal and OCD chondrogenic pellets produced the larger amount of safranin O-stained 
proteoglycans compared with SONK pellets (a-c, red). Lipid vacuoles were observed in normal and OCD 
chondrocytes after adipogenic induction (a and b, red). Calcium depositions were induced by osteogenic 
treatments in normal cartilage- and OCD-derived cells (a and b, brown). On the other hand, neither 
adipogenesis nor osteogenesis was induced in SONK-derived cells (c). The Bern pellet histology score was 
higher in normal and OCD pellets than in SONK pellets (d). Staining density of oil red O and von Kossa was 
lower in SONK-derived cells than in normal and OCD chondrocytes after the treatment of adipogenic and 
osteogenic induction (e and f). Bars, 100 μm. *p < 0.05. 
 
Fig. 3. Expression pattern of chondrogenic marker genes. Expression of COL2A1 and SOX9 was more 
activated in normal and OCD chondrogenic pellets than in SONK pellets (a and b). However, the difference 
among normal, OCD, and SONK chondrogenic pellets was not observed in SOX5/6 expression (c and d). *p 
< 0.05. 
 
Fig. 4. CD166, a MSC surface marker, was detected in the cells of normal and loose fragment cartilages (a-c, 
brown in the transitional zone of articular cartilage). Normal cartilage (a). OCD loose fragment (b). SONK 
loose fragment (c). Negative control in the absence of an anti-CD166 antibody (d). CD166-positive cell ratio 
was higher in normal cartilages and OCD fragments than in SONK fragments (e). Normal cartilages and 
OCD fragments showed higher staining densities of CD166 compared with SONK loose fragment cartilages 
(f). Bars, 100 μm. *p < 0.05. 
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